Director, Medical Affairs Strategy (Women's Health)

Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada, Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the U.S., Canada, and Europe, a diverse pipeline of early- to late-stage assets, and in-house advanced technology capabilities, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.

Job Overview

The Director, Medical Strategy (Women’s Health) will be a key member of the Medical Affairs team reporting to the Executive Director, Medical Affairs Strategy.  

The job is responsible for strategic direction and alliance management for the Women’s Health (WH) therapeutic area and set strategy for both internal company programs and external facing interactions. This job will effectively lead and communicate with cross-functional team members to share and gain insights that help SMPA meet the unmet medical needs in Women’s Health – Endometriosis and Uterine Fibroids.  The role will also collaborate closely with Commercial leadership and advance patient advocacy efforts to ensure that Medical Affairs activities align with patient focused programs.

Job Duties and Responsibilities

• Develops and aligns Medical Affairs strategic plans with brand strategic imperatives that support impactful insights, data generation, and data communication plans to support education and awareness to HCP stakeholders and healthcare payers.
• Serve as a Medical Strategy lead for the Pfizer alliance for Women’s Health, ensuring coordination and alignment of all women’s health Medical Affairs activities and budget within SMPA and with alliance partners.
• Oversee the strategy and development of Medical Affairs plans and scientific platforms for relugolix combination therapy.
• Develop the Medical Strategy Team within the US to provide medical training, evaluation, motivation, and control of activities in alignment with the company’s corporate strategies and objectives.
• Ensure cross-functional medical alignment with the US Field Medical team, Medical Communications & Operations, RWE & HEOR and ex-US colleagues.
• Direct the implementation of plans that will be executed through multi-modal medical education channels, including publications, presentations, congresses, advisory boards, CME, medical symposia and other channels in support of relugolix combination therapy commercialization.
• Oversee the development and implementation of detailed scientific Publication Plans & Medical Advisory Board Plan.
• Play a highly visible role during exchanges within the medical/scientific community to develop close relationships with a group of scientific key opinion leaders.
• Work closely with the commercial organization to bring the medical perspective to commercial strategies and tactics, aligning with Marketing & Market Access to collaborate on the most efficient and effective ways for office and field forces to work together.
• Partner with the Research & Development organization for ongoing and post- Represent the Medical Affairs department on the lifecycle team for WH to provide Medical Affairs input to R&D.
• Define and attend relevant medical and scientific conferences to support speakers and presenters, ensure the success of publication/communication goals, and participate in the collection and reporting of competitive intelligence within company guidelines.
• Provide input into a long-term Medical Education program.
• Provide strategy and oversight for the development of a supportive US Investigator Initiated Study program.
• Provide detailed and compliant medical review and approval of external resources, communications, and publications – ensuring medical accuracy, relevance, and fair-balance.
• Develops and oversees Medical Affairs annual operating budget.
• Manages direct repo